These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 16941461

  • 1. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
    Zesiewicz TA, Sullivan KL, Hauser RA, Sanchez-Ramos J.
    Mov Disord; 2006 Nov; 21(11):1998-2001. PubMed ID: 16941461
    [Abstract] [Full Text] [Related]

  • 2. Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
    Zesiewicz TA, Sullivan KL, Maldonado JL, Tatum WO, Hauser RA.
    Mov Disord; 2005 Sep; 20(9):1205-9. PubMed ID: 15954135
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of levetiracetam in Huntington disease.
    de Tommaso M, Di Fruscolo O, Sciruicchio V, Specchio N, Cormio C, De Caro MF, Livrea P.
    Clin Neuropharmacol; 2005 Sep; 28(6):280-4. PubMed ID: 16340384
    [Abstract] [Full Text] [Related]

  • 4. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
    Kenney C, Hunter C, Davidson A, Jankovic J.
    Mov Disord; 2007 Jan; 22(1):10-3. PubMed ID: 17078062
    [Abstract] [Full Text] [Related]

  • 5. Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial.
    Vitale C, Marconi S, Di Maio L, De Michele G, Longo K, Bonavita V, Barone P.
    Mov Disord; 2007 Dec; 22(16):2359-64. PubMed ID: 17894335
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.
    Saft C, Lauter T, Kraus PH, Przuntek H, Andrich JE.
    BMC Neurol; 2006 Feb 28; 6():11. PubMed ID: 16507108
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Levetiracetam in social phobia: a placebo controlled pilot study.
    Zhang W, Connor KM, Davidson JR.
    J Psychopharmacol; 2005 Sep 28; 19(5):551-3. PubMed ID: 16166192
    [Abstract] [Full Text] [Related]

  • 12. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.
    Eur J Paediatr Neurol; 2008 Jul 28; 12(4):321-7. PubMed ID: 17950011
    [Abstract] [Full Text] [Related]

  • 13. Zotepine in Huntington's disease.
    Bonelli RM, Niederwieser G, Lahousen T, Hofmann P.
    Hum Psychopharmacol; 2003 Apr 28; 18(3):227-9. PubMed ID: 12672176
    [Abstract] [Full Text] [Related]

  • 14. Unified Huntington's disease rating scale: a follow up.
    Siesling S, van Vugt JP, Zwinderman KA, Kieburtz K, Roos RA.
    Mov Disord; 1998 Nov 28; 13(6):915-9. PubMed ID: 9827615
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chorea in a patient with cerebral palsy: treatment with levetiracetam.
    Recio MV, Hauser RA, Louis ED, Radhashakar H, Sullivan KL, Zesiewicz TA.
    Mov Disord; 2005 Jun 28; 20(6):762-4. PubMed ID: 15747368
    [Abstract] [Full Text] [Related]

  • 17. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
    von Stuelpnagel C, Holthausen H, Kluger G.
    Eur J Paediatr Neurol; 2007 Nov 28; 11(6):341-5. PubMed ID: 17442601
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.